Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
The development of tumor necrosis factor alpha (TNF-) inhibitors is probably one of the most significant advancement in the management of a number of inflammatory rheumatic disorders to date. High efficacy of the treatment is associated with relatively rare and very heterogeneous adverse reactions....
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Termedia Publishing House
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c12f29a7f5784476be57d07b8b576008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!